ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 27.09.
| Share Price | ₹5,492.3 | Feb 23,2026 |
| Market Cap | ₹65,687.3 Cr | |
| Earnings-TTM | ₹2,424.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 27.09x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹65,687.3 Cr] as on Feb 23,2026
(/) Earnings [ ₹2,424.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 27.09x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 27.09 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 29.66x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALKEM LABORATORIES | 2,424.46 | 27.09 | 65,687.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.78 | 415,613.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 67.41 | 167,105.0 |
| CIPLA LTD | 4,544.70 | 23.57 | 107,120.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 64.23 | 145,926.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.80 | 109,088.0 |
| MANKIND PHARMA LTD | 1,796.65 | 47.01 | 84,468.2 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.52 | 91,356.0 |
| LUPIN LTD | 4,669.18 | 21.98 | 102,611.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 19.01 | 66,792.2 |
| ABBOTT INDIA LTD | 1,524.13 | 36.92 | 56,264.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.52x |
| Max industry PE | 67.41x |
| Median industry PE | 27.09x |
| Average industry PE | 34.85x |
You may also like the below Video Courses